Abstract
Purpose
In the United States, an estimated 8500 HIV (human immunodeficiency virus) positive women gave birth in 2014. This rate appears to be increasing annually. Our objective is to examine obstetrical outcomes of pregnancy among HIV-positive women.
Methods
A population-based cohort study was conducted using the Nationwide Inpatient Sample database (2003–2011) from the United States. Pregnant HIV-positive women were identified and compared to pregnant women without HIV. Multivariate logistic regression was used to estimate the adjusted effect of HIV status on obstetrical and neonatal outcomes.
Results
Among 7,772,999 births over the study period, 1997 were in HIV-positive women (an incidence of 25.7/100,000 births). HIV-infected patients had greater frequency of pre-existing diabetes and chronic hypertension, and use of cigarettes, drugs, and alcohol during pregnancy (p < 0.001). Upon adjustment for baseline characteristics, HIV-infected women had greater likelihood of antenatal complications: preterm premature rupture of membranes (OR 1.35, 95% CI 1.14–1.60) and urinary tract infections (OR 3.02, 95% CI 2.40–3.81). Delivery and postpartum complications were also increased among HIV-infected women: cesarean delivery (OR 3.06, 95% CI 2.79–3.36), postpartum sepsis (OR 8.05, 95% CI 5.44–11.90), venous thromboembolism (OR 2.21, 95% CI 1.46–3.33), blood transfusions (OR 3.67, 95% CI 3.01–4.49), postpartum infection (OR 3.00, 95% CI 2.37–3.80), and maternal mortality (OR 21.52, 95% CI 12.96–35.72). Neonates born to these mothers were at higher risk of prematurity and intrauterine growth restriction.
Conclusion
Pregnancy in HIV-infected women is associated with adverse maternal and newborn complications. Pregnant HIV-positive women should be followed in high-risk healthcare centers.
Similar content being viewed by others
References
World Health Organization (2015) Media Centre. HIV/AIDS Fact Sheet No 360. http://www.who.int/mediacentre/factsheets/fs360/en/. Accessed 25 April 2016
HIV Among Women. Fast Facts. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/group/gender/women/. Accessed 1 Aug 2016
Centers for Disease Control and Prevention (2015) HIV Surveillance Report, 2014; vol. 26. http://cdc.gov/cdc-info/requestform.html. Accessed 7 April 2016
CDC CfDCaPNCfHA, Viral Hepatitis, STD, and TB Prevention (2016 ) Division of HIV/AIDS Prevention. HIV among pregnant women, infants, and children 2016. http://www.cdc.gov/hiv/group/gender/pregnantwomen/. Accessed March 2016
Reitter A, Stucker AU, Linde R, Konigs C, Knecht G, Herrmann E et al (2014) Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort. HIV Med 15:525–536
Yudin MH, Caprara D, MacGillivray SJ, Urquia M, Shah RR (2016) A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant women. J Obstet Gynaecol Can 38:35–40
Marti C, Pena JM, Bates I, Madero R, de Jose I, Pallardo LF et al (2007) Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003. Acta Obstet Gynecol Scand 86:409–415
Brocklehurst P, French R (1998) The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 105:836–848
Ewing AC, Datwani HM, Flowers LM, Ellington SR, Jamieson DJ, Kourtis AP (2016) Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011. Am J Obstet Gynecol 215:499e1–499e8
Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ (2006) Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994–2003. AIDS (London, England) 20:1823–31
Gonzalez-Tome MI, Ramos Amador JT, Guillen S, Solis I, Fernandez-Ibieta M, Munoz E et al (2008) Gestational diabetes mellitus in a cohort of HIV-1 infected women. HIV Med 9:868–874
Lopez M, Figueras F, Hernandez S, Lonca M, Garcia R, Palacio M, et al (2012) Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS (London, England) 26:37–43
Kourtis AP, Schmid CH, Jamieson DJ, Lau J (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (London, England) 21:607–615
Rasmussen LD, Dybdal M, Gerstoft J, Kronborg G, Larsen CS, Pedersen C et al (2011) HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med 12:202–210
Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG (2008) Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 19:95–97
Weiss AJ, Elixhauser A (2006) Overview of Hospital Stays in the United States, 2012: Statistical Brief #180. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Health Care Policy and Research (US)
Berthelsen CL (2000) Evaluation of coding data quality of the HCUP National Inpatient Sample. Top Health Inform Manag 21:10–23
NIS Description of Data Elements. https://www.hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp. Accessed 1 Aug 2016
Reshi P, Lone IM (2010) Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281:781–792
Gilling-Smith C, Nicopoullos JD, Semprini AE, Frodsham LC (2006) HIV and reproductive care—a review of current practice. BJOG 113:869–878
Barnhart N, Shannon M, Weber S, Cohan D (2009) Assisted reproduction for couples affected by human immunodeficiency virus in California. Fertil Steril 91:1540–1543
Frodsham LC, Boag F, Barton S, Gilling-Smith C (2006) Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil Steril 85:285–289
Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plan Perspect 33(144–52):65
Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al (2008) Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS (London, England) 22:289–299
European Collaborative S (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465
Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P et al (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340:1317–1319
Pena JE, Thornton MH, Sauer MV (2003) Assessing the clinical utility of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus type 1 serodiscordant couples: report of 113 consecutive cycles. Fertil Steril 80:356–362
Gingelmaier A, Wiedenmann K, Sovric M, Mueller M, Kupka MS, Sonnenberg-Schwan U et al (2011) Consultations of HIV-infected women who wish to become pregnant. Arch Gynecol Obstet 283:893–898
Kourtis AP, Ellington S, Pazol K, Flowers L, Haddad L, Jamieson DJ (2014) Complications of cesarean deliveries among HIV-infected women in the United States. AIDS (London, England) 28:2609–2618
Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF et al (1998) Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 280:55–60
(1999). The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 340:977–987
European Mode of Delivery C (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039
Committee on Obstetric P (2001) ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet 73:279–281
Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y et al (2013) Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Am J Obstet Gynecol 209:335.e1–335.e12
Islam S, Oon V, Thomas P (2010) Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy. J Obstet Gynaecol 30:38–40
CDC (2006) Achievements in Public Health: Reduction in Perinatal Transmission of HIV Infection—United States, 1985–2005
Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA (2008) Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS (London, England) 22:973–981
Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE et al (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468–474
Park JC, Buono D, Smith DK, Peipert JF, Sobel J, Rompalo A et al (2002) Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 187:581–588
Bansil P, Jamieson DJ, Posner SF, Kourtis AP (2007) Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Women’s Health 16:159–162
Graham WHJ (2003) Measuring and estimating maternal mortality in the era of HIV/AIDS. Workshop on HIV/AIDS and adult mortality in developing countries. Population Division, New York
Aagaard-Tillery KM, Lin MG, Lupo V, Buchbinder A, Ramsey PS (2006) Preterm premature rupture of membranes in human immunodeficiency virus-infected women: a novel case series. Infect Dis Obstet Gynecol 2006:53234
Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP et al (1995) The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 173:585–589
Xiao PL, Zhou YB, Chen Y, Yang MX, Song XX, Shi Y et al (2015) Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth 15:246
Kourtis AP, Fowler MG (2011) Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis 204:493–494
Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA (2007) Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS (London, England) 21:1019–1026
Auerbach E, Aboulafia DM (2012) Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy. Semin Thromb Hemost 38:830–838
Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S et al (2012) Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 206:1695–1705
Ezechi OC, Gab-Okafor CV, Oladele DA, Kalejaiye OO, Oke BO, Ohwodo HO et al (2013) Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health 17:160–168
HIV and AIDS in Canada. Surveillance Report to December 31, 2008. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, 2009
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study did not receive any funding.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study exclusively used publicly available data; hence, according to the Tri-Council Policy Statement (2010), institutional review board approval was not required.
Rights and permissions
About this article
Cite this article
Arab, K., Spence, A.R., Czuzoj-Shulman, N. et al. Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet 295, 599–606 (2017). https://doi.org/10.1007/s00404-016-4271-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4271-y